Lambert Eaton Myasthenic Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Lambert Eaton Myasthenic stocks.

Lambert Eaton Myasthenic Stocks Recent News

Date Stock Title
Apr 26 BMRN BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Q1 2024 Earnings Call Transcript
Apr 26 BMRN BioMarin Pharmaceutical First Quarter 2024 Earnings: EPS Beats Expectations
Apr 26 BMRN Pfizer hemophilia gene therapy arrives in US to uncertain future
Apr 25 BMRN Why Caterpillar Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Apr 25 BMRN BioMarin (BMRN) Beats on Q1 Earnings, Voxzogo Drives Sales
Apr 25 BMRN BioMarin drops drug programs in pipeline cull
Apr 25 BMRN Q1 2024 Biomarin Pharmaceutical Inc Earnings Call
Apr 25 BMRN Biomarin Pharmaceutical Inc (BMRN) Q1 2024 Earnings Call Transcript Highlights: Strong Growth ...
Apr 25 BMRN BioMarin Pharmaceutical, Inc. (BMRN) Q1 2024 Earnings Call Transcript
Apr 25 BMRN BioMarin Pharmaceutical Inc. 2024 Q1 - Results - Earnings Call Presentation
Apr 24 BMRN BioMarin (BMRN) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
Apr 24 BMRN BioMarin Pharmaceutical Inc. (BMRN) Q1 2024 Earnings: Surpasses Revenue and EPS Estimates
Apr 24 BMRN BioMarin updated 2024 guidance sees EPS raise, but no change to revenue
Apr 24 BMRN BioMarin Pharmaceutical (BMRN) Tops Q1 Earnings Estimates
Apr 24 BMRN BioMarin Pharmaceutical Non-GAAP EPS of $0.71 beats by $0.11, revenue of $648.83M misses by $2.98M
Apr 24 BMRN BioMarin Reports Record Financial Results for the First Quarter 2024
Apr 23 BMRN BioMarin Pharmaceutical Q1 2024 Earnings Preview
Apr 23 BMRN Is a Surprise Coming for BioMarin (BMRN) This Earnings Season?
Apr 23 BMRN AstraZeneca (AZN) to Report Q1 Earnings: Here's What to Expect
Apr 22 BMRN BioMarin Pharmaceutical Investors to Focus Q1 on Strategic Review, Cost-Cutting Measures, UBS Says
Lambert Eaton Myasthenic

Lambert Eaton Myasthenic Syndrome (LEMS) is a rare autoimmune disorder that affects the neuromuscular junction, the area where nerve cells and muscle cells meet. It is characterized by muscle weakness, fatigue, and difficulty with coordination and balance. It is caused by antibodies that attack the proteins that help nerve cells communicate with muscle cells. Treatment typically involves medications to reduce the effects of the antibodies and to improve muscle strength.

Browse All Tags